Literature DB >> 24022813

Validation of healthcare administrative data for the diagnosis of epilepsy.

C Franchi1, G Giussani, P Messina, M Montesano, S Romi, A Nobili, I Fortino, A Bortolotti, L Merlino, E Beghi.   

Abstract

BACKGROUND: Administrative databases have become an important tool to monitor diseases. Patients with epilepsy could be traced using disease-specific codes and prescriptions, but formal validation is required to obtain an accurate case definition. The aim of the study was to correlate administrative data on epilepsy with an independent source of patients with epilepsy in a district of Lombardy, Northern Italy, from 2000 to 2008.
METHODS: Data of nearly 320 600 inhabitants in the district of Lecco collected from the Drug Administrative Database of the Lombardy Region were analysed. Among them were included patients who fulfilled the International Classification of Diseases 9 (ICD-9) codes and/or the disease-specific exemption code for epilepsy and those who had at least one EEG record and took antiepileptic drugs (AEDs) as monotherapy or in variable combinations. To ascertain epilepsy cases, 11 general practitioners (GPs) with 15 728 affiliates were contacted. Multiple versions of the diagnostic algorithm were developed using different logistic regression models and all combinations of the four independent variables.
RESULTS: Among the GP affiliates, 71 (4.5/1000) had a gold standard diagnosis of epilepsy. The best and most conservative algorithm included EEG and selected treatment schedules and identified 61/71 patients with epilepsy (sensitivity 85.9%, CI 76.0% to 92.2%) and 15 623/15 657 patients without epilepsy (specificity 99.8%,CI 99.7% to 99.8%). The positive and negative predictive values were 64.2% and 99.9%. Sensitivity (86.7%) and the positive predictive value (68.4%) increased only slightly when patients with single seizures were included.
CONCLUSIONS: A diagnostic algorithm including EEG and selected treatment schedules is only moderately sensitive for the detection of epilepsy and seizures. These findings apply only to the Northern Italian scenario.

Entities:  

Keywords:  EPILEPSY; NEUROEPIDEMIOLOGY; PHARMACOEPIDEMIOLOGY

Mesh:

Substances:

Year:  2013        PMID: 24022813     DOI: 10.1136/jech-2013-202528

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  16 in total

1.  Accuracy of claims-based algorithms for epilepsy research: Revealing the unseen performance of claims-based studies.

Authors:  Lidia M V R Moura; Maggie Price; Andrew J Cole; Daniel B Hoch; John Hsu
Journal:  Epilepsia       Date:  2017-02-15       Impact factor: 5.864

2.  Identification of prevalent patients with epilepsy using administrative data: the Tuscany experience.

Authors:  Irene Bellini; Laura Policardo; Gaetano Zaccara; Pasquale Palumbo; Eleonora Rosati; Elena Torre; Paolo Francesconi
Journal:  Neurol Sci       Date:  2017-01-04       Impact factor: 3.307

Review 3.  The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?

Authors:  Gianluca Trifirò; Rosa Gini; Francesco Barone-Adesi; Ettore Beghi; Anna Cantarutti; Annalisa Capuano; Carla Carnovale; Antonio Clavenna; Mirosa Dellagiovanna; Carmen Ferrajolo; Matteo Franchi; Ylenia Ingrasciotta; Ursula Kirchmayer; Francesco Lapi; Roberto Leone; Olivia Leoni; Ersilia Lucenteforte; Ugo Moretti; Alessandro Mugelli; Luigi Naldi; Elisabetta Poluzzi; Concita Rafaniello; Federico Rea; Janet Sultana; Mauro Tettamanti; Giuseppe Traversa; Alfredo Vannacci; Lorenzo Mantovani; Giovanni Corrao
Journal:  Drug Saf       Date:  2019-03       Impact factor: 5.606

4.  Epilepsy Among Elderly Medicare Beneficiaries: A Validated Approach to Identify Prevalent and Incident Epilepsy.

Authors:  Lidia M V R Moura; Jason R Smith; Deborah Blacker; Christine Vogeli; Lee H Schwamm; Andrew J Cole; Sonia Hernandez-Diaz; John Hsu
Journal:  Med Care       Date:  2019-04       Impact factor: 2.983

5.  Comparison of Health Care Resource Utilization by Immigrants Versus Native Elderly People.

Authors:  Carlotta Franchi; Marta Baviera; Marco Sequi; Laura Cortesi; Mauro Tettamanti; Maria Carla Roncaglioni; Luca Pasina; Codjo Djade Dignefa; Ida Fortino; Angela Bortolotti; Luca Merlino; Pier Mannuccio Mannucci; Alessandro Nobili
Journal:  J Immigr Minor Health       Date:  2016-02

6.  Validity of ICD-9-CM codes for breast, lung and colorectal cancers in three Italian administrative healthcare databases: a diagnostic accuracy study protocol.

Authors:  Iosief Abraha; Diego Serraino; Gianni Giovannini; Fabrizio Stracci; Paola Casucci; Giuliana Alessandrini; Ettore Bidoli; Rita Chiari; Roberto Cirocchi; Marcello De Giorgi; David Franchini; Maria Francesca Vitale; Mario Fusco; Alessandro Montedori
Journal:  BMJ Open       Date:  2016-03-25       Impact factor: 2.692

7.  Patient-reported financial barriers to adherence to treatment in neurology.

Authors:  Lidia Mvr Moura; Eli L Schwamm; Valdery Moura Junior; Michael P Seitz; Daniel B Hoch; John Hsu; Lee H Schwamm
Journal:  Clinicoecon Outcomes Res       Date:  2016-11-17

8.  Estimating the Prevalence of Treated Epilepsy Using Administrative Health Data and Its Validity: ESSENCE Study.

Authors:  Seo Young Lee; Soo Eun Chung; Dong Wook Kim; So Hee Eun; Hoon Chul Kang; Yong Won Cho; Sang Do Yi; Heung Dong Kim; Ki Young Jung; Hae Kwan Cheong
Journal:  J Clin Neurol       Date:  2016-06-03       Impact factor: 3.077

Review 9.  Causal inference as an emerging statistical approach in neurology: an example for epilepsy in the elderly.

Authors:  Lidia Mvr Moura; M Brandon Westover; David Kwasnik; Andrew J Cole; John Hsu
Journal:  Clin Epidemiol       Date:  2016-12-30       Impact factor: 4.790

10.  Validating epilepsy diagnoses in routinely collected data.

Authors:  Beata Fonferko-Shadrach; Arron S Lacey; Catharine P White; H W Rob Powell; Inder M S Sawhney; Ronan A Lyons; Phil E M Smith; Mike P Kerr; Mark I Rees; W Owen Pickrell
Journal:  Seizure       Date:  2017-10-13       Impact factor: 3.184

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.